Aims Hospital readmission after implantation of cardioverter/defibrillators has a major impact on quality of life and cost-effectiveness in defibrillator patients. Rehospitalization has not been studied in large patient populations with modern transvenous defibrillation systems.
Introduction
The implantable cardioverter/defibrillator has been shown to be remarkably effective in preventing sudden cardiac death and total mortality in patients with life threatening ventricular tachyarrhythmia [1, 2] . Recent studies show favourable results for defibrillators implanted in high risk patients with a prophylactic indication [3, 4] . Since changes in the socioeconomic climate force justification of the use of expensive medical interventions [5] , potential benefits of defibrillator therapy have to be characterized focusing on softer end-points such as cardiac morbidity, quality of life and cost-effectiveness. Recent studies addressed hospital readmission as a severe adverse event of defibrillator therapy [6] and as a major factor of cost-effectiveness analysis [7] . ICD implantation might decrease the frequency and duration of hospitalization in high risk patients and translate into cost savings for the health care provider. This is the first single centre study to systematically and prospectively analyse incidence, reasons, time in follow-up, duration and predictors of hospital readmission after successful implantation of modern transvenous ICD systems.
Methods

Patient population and follow-up
The study population consisted of 180 patients who underwent successful implantation of a transvenous defibrillation system with stored electrograms or RR interval recordings. All devices were implanted as single chamber systems: 105 devices (58%) were placed in a left and two devices (1%) in a right subpectoral pocket, 73 devices (41%) were placed in an abdominal pocket. Access to lead placement was obtained by cephalic vein cutdown. All leads were fixed by double anchoring sleeves with non-resorbable strings. Of the devices implanted 139 were manufactured by Medtronic (Minneapolis, Minn.), 24 by CPI (St. Paul, Minn.), nine by Sulzer Intermedics (Angleton, Tex.), six by Telectronics (Englewood, Denver), and two by Ventritex (Sunnyvale, Calif.).
Clinical characteristics of the patients are depicted in Table 1 . At the time of hospital discharge 11 patients (6%) were on amiodarone, 65 (36%) on d/l-sotalol, 25 (14%) on class I antiarrhythmic drugs, 12 (7%) on beta-blocker and 10 (6%) on combined (class I+sotalol) treatment. Of the patients with coronary artery disease 77 (68%) were either on beta-blocker or on d/l-sotalol, 11 patients (10%) were on amiodarone.
Antitachycardia pacing was programmed in patients with documented or suspected monomorphic ventricular tachycardia with a cut-off rate of 10 beats . min 1 below the rate of the clinical ventricular tachycardia. In patients with only a history of ventricular fibrillation a cut-off rate of 190 beats . min 1 for shock treatment was programmed. Enhanced detection criteria were not available in all devices and not programmed at first hospital discharge.
Follow-up of this prospective study began on the day of hospital discharge after first ICD implantation. Hospital readmission was defined as readmission to the first or any other hospital for more than 12 h. The patients were also routinely seen in the outpatient clinic of the implanting centre every 3 months. Pertinent information was obtained by reviewing patients' hospital records and by telephone contact with patients, their families, or private physicians. No patient was lost to follow-up.
Classification of hospital readmissions
Hospital readmissions were classified as cardiac or non-cardiac by consensus between two investigators (T.K., W.J.). Cardiac readmissions were subclassified in arrhythmia-related and non-arrhythmia-related. Arrhythmia-related readmissions were subdivided into those caused by ventricular tachyarrhythmia with and without appropriate shock, supraventricular tachyarrhythmia with and without inappropriate shock, deviceand lead-related complications and battery depletion. Non-arrhythmia-related cardiac readmissions were congestive heart failure and ischaemia (i.e. acute myocardial infarction, unstable angina). When patients were admitted for a combination of the above reasons, the dominant problem was considered to be the reason for readmission.
Statistical analysis
Rates of readmission were determined by dividing the number of hospitalizations experienced by the total number of person-years of follow-up for both individual patients and for groups. The data are reported as mean, maximum and minimum values and as standard deviation [ SD] . The probabilities of freedom from cardiac-and arrhythmia-related readmission were estimated by the method of Kaplan and Meier, and the Mann-Whitney test was used for statistical comparison. As predictors of the time to first cardiac-or arrhythmiarelated readmission and rehospitalization time per patient-year of follow-up age, gender, NYHA classification, coronary heart disease and left ventricular ejection fraction were analysed. For this purpose age was dichrotomized at 60 and left ventricular ejection fraction at 30%. The Mann-Whitney test was used for predictor analysis. A P-value of <0·05 was considered statistically significant for all tests.
Results
There were 156 readmissions in 79 patients (44%) after a mean follow-up period of 25 18 months . The rate of hospital readmission was 0·87 per patient during the time followed and 0·46 per patient-year of follow-up. One hundred and thirty readmissions (83%) in 72 
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patients (40%) were cardiac-related with a cardiac readmission rate of 0·38 per patient-year of follow-up. One hundred and ten readmissions (71%) in 34 patients (19%) were arrhythmia-related. The mean time to first hospital readmission was 12 9 months for arrhythmiarelated and 20 16 months for other cardiac-related reasons (P<0·05, Mann-Whitney test) ( Twenty patients (11%) died during follow-up. Reasons were congestive heart failure in 10 patients (6%), myocardial infarction in two patients (1%), sudden cardiac death in three patients (2%), cerebral or gastrointestinal bleeding in three patients (2%), sepsis in one patient (0·6%) and unknown in one patient (0·6%).
Arrhythmia-related readmissions
Forty readmissions (26%) in 20 patients (11%) were caused by multiple appropriate shock interventions due to recurrent ventricular tachyarrhythmia. In 12 patients antiarrhythmic treatment was changed, four patients were put on amiodarone. In one patient defibrillator reprogramming was performed with modified antitachycardia pacing for avoidance of shock interventions. One patient with coronary artery disease and a left ventricular ejection fraction below 30% had to stay in the hospital for 118 days and suppression of recurrent slow ventricular tachycardia could only be achieved by additional dual chamber pacing and combined class III and class I antiarrhythmic drug treatment.
The occurrence of atrial fibrillation or atrial flutter with rapid ventricular response caused 19 readmissions (12%) in 18 patients (10%). In five readmissions (3%) in five patients (3%) rapid atrial fibrillation was the cause of inappropriate shock intervention. In two patients a successful internal cardioversion with the ICD defibrillation system was performed, in six patients antiarrhythmic treatment was changed, three patients were put on amiodarone. In two patients defibrillator reprogramming was performed with use of rate stability as an enhanced detection criterion for atrial fibrillation in one patient and an altered zone of detection for ventricular tachyarrhythmias in the other patient. In one patient ablation of atrial flutter was successfully performed.
Lead-and device-related readmissions
Lead-related complications caused 13 readmissions (8%) in 13 patients (7%). There were six lead fractures, four dislodgements, and three insulation defects. All insulation defects were diagnosed after inappropriate ICD intervention, all fractures and lead dislodgements were diagnosed with biplane chest X-ray during routine follow-up. Lead fractures and dislodgements were diagnosed at 13·7 12·7 subcutaneous patch leads. Of the four dislodged leads three were right ventricular leads with passive fixation and one was a superior vena cava lead. Insulation defects were diagnosed 8 6·6 [1-14] months after implantation. Three of these leads had a silicone rubber and one lead polyurethane insulation. All lead-related complications had to be surgically revised.
Device-related complications caused nine readmissions (6%) in nine patients (5%). The cause was generator pocket infection in three patients and pocket haematoma or seroma in four patients. All infections occurred in patients with an abdominal generator pocket. Of the four haematoma and seroma three occurred after left subpectoral and one after abdominal implantation. One patient was readmitted for abdominal device dislodgement causing an ileus and one patient for inappropriate antibradycardia pacing. Device-related complications occurred 20·1 18·3 [1-52] months after first hospital discharge, all pocket infections led to a complete system revision with a hospital stay of 48·3 11·8 days.
Readmission for battery depletion
Battery depletion was the reason for 29 hospital readmissions (19%) in 29 patients (16%). Time to hospital readmission was 38 8·9 months . In one of the patients with generator replacement, device replacement was followed by a pocket infection which required complete system revision. The duration of hospital stay for generator replacement was 14 6 days .
Other cardiac-related readmissions
There were 12 readmissions (8%) in eight patients (4%) for the treatment of congestive heart failure. Eight readmissions (5%) in four patients (2%) were caused by unstable angina. Treatment was modification of antianginal medication in all patients. Additional interventional therapy was indicated in none of these patients.
Predictors of readmission
The P-values of the analysed predictors for the time to first cardiac-and arrhythmia-related readmission and rehospitalization time per patient-year of follow-up are summarized in Table 2 . None of the tested clinical variables, i.e. age, gender, NYHA classification, coronary artery disease and left ventricular ejection fraction, were able to predict the time to first hospital readmission for cardiac-and arrhythmia-related reasons. Age >60 years was identified as an independent predictor for rehospitalization time per patient-year of follow-up for both cardiac-related (P<0·005) and arrhythmia-related reasons (P<0·05).
Discussion
Incidence and duration of readmission
This first single centre study of hospital readmission in patients with modern, transvenous ICD systems demonstrates an overall readmission rate of 0·46 per patientyear of follow-up. The time to first hospitalization was 12 9 months for arrhythmia-related and 20 16 months for other cardiac-related reasons. The MADIT investigators [7] reported 360 hospitalizations during 2254 person-months of observation in 89 ICD patients (47% of patients with epicardial ICD system). Fahy et al. [8] reported a 0·72 readmission rate per year of follow-up in a series of 34 patients with 48% epicardial systems and a short medium follow-up of 19 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] months. The significantly higher number of readmissions (both studies did not include rehospitalizations for battery depletion) in these two series might, in part, be explained by the lower mean ejection fraction of 27% and 34%, and a higher mean age of 62 years and 67 years, respectively.
The AVID investigators [9] compared the probability of rehospitalization in the ICD group (93% transvenous systems) with a 59·5/74·8/83·3% probability in the first, second and third year after ICD implantation as compared to 55·6/64·7/75·5% in the conventional arm, 
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respectively. Valenti et al. [10] reported a reduction of hospital readmission in the 12 months after as compared to the 12 months before first defibrillator implantation (3·3 vs 0·9 readmissions per patient year of follow-up). But treatment and monitoring of heart failure and ventricular and supraventricular arrhythmia are often significantly different before and after device implantation and the performed comparison might thus not sufficiently compare significance of rehospitalization in high risk patients with and without defibrillator.
Our results confirm Fahy et al. [8] documenting an 83% rate of cardiac readmissions as arrhythmia-related and an earlier occurrence of arrhythmia-related as compared to overall cardiac-related readmissions. Since former studies [11] have shown an accumulation of arrhythmia occurrence in the first few months after implantation the rate of hospital readmission might still go down in future studies with a still longer follow-up period.
Reasons for readmission and prevent strategies
The main reasons for readmissions were multiple appropriate shock treatments (26%) and the occurrence of atrial fibrillation or atrial flutter with or without inappropriate shock (12%). Fahy et al. [8] found 24% ventricular arrhythmias and 24% supraventricular arrhythmias as the cause for hospital readmission. These findings confirm the data of Nunain et al. [12] with recurrent arrhythmias as a significant source of morbidity in defibrillator patients. The majority of 68% of patients with coronary artery disease in our study had either been on beta-blocker or on d/l-sotalol, 42% of patients were on a class III antiarrhythmic drug, similar to the drug regimen of former studies [12] . Antitachycardia pacing had been programmed in all patients with documented or suspected ventricular tachycardia, since it dramatically reduces the delivery of high energy shocks in patients with ventricular tachycardia [13] . Treatment of patients with readmissions for arrhythmia recurrence was, in most patients, a change of the antiarrhythmic drug regimen with a change to amiodarone in 23% of cases and a combination of two antiarrhythmic drugs in 23·5% of cases. Encouraging results of advanced detection algorithms with single-or dualchamber defibrillators for avoidance of inappropriate shocks have been published [14, 15] but have not been systematically studied as a preventive strategy for avoidance of hospital readmission of patients due to inappropriate intervention. In case of drug-refractory recurrence of ventricular and supraventricular tachycardia as a cause of readmission ablation techniques might gain more importance in the future [16] [17] [18] . The possibility of dual-chamber, rate-responsive pacing in dual-chamber systems may also decrease the incidence of readmission in patients requiring chronic pacing.
Hardware-related problems caused 14% of all hospital readmissions with 8% lead-related and 6% device-related readmissions. These data confirm results of large follow-up studies [12, 19] . In our small series these complications could not be explained by specific hardware used or implantation technique. Future studies will have to show if advanced lead technology, reduced generator size and pectoral device implantation will help reduce the still high rate of hardware problems and thus hospital readmission.
The impact of battery depletion which makes up for 19% of all hospital readmissions in this study was not analysed in other studies [7, 8, 10] . Batteries had a longevity of 38 8·9 months and readmission for device change and thus overall readmission rate should significantly drop with future devices offering an advanced battery technology. The long mean duration of hospital stay for battery depletion in this series was due to the long hospital stay in single patients with system infection and an indicated two step procedure with explantation of the whole system, antibiotic treatment and consecutive implantation of a new system.
Predictors of hospital readmission
In this series no independent predictor could be identified for the time to first cardiac-and arrhythmia-related readmission. Age >60 years was found as a significant predictor of rehospitalization time for both cardiac-and arrhythmia-related reasons. Fahy et al. [8] found a New York Heart association class III and IV to significantly predict a shorter time to first cardiac-related readmission using a cox regression analysis. Predictors such as underlying heart disease and ejection fraction should be reanalysed in future studies with larger patient cohorts.
Study limitations
Hospital readmissions not only to the implanting centre were analysed and the indication for patient admission might vary between different institutions. Since treatment of a large ICD patient cohort cannot exclusively be performed by the implanting centre realistic numbers of hospital readmission have to include admissions to smaller, more unexperienced institutions with a possibly different admission policy.
Conclusions
Hospital readmission decreases significantly in recipients of modern transvenous ICD systems, and rehospitalization time is significantly longer in the patient cohort >60 years. Further studies are needed to systematically investigate prevent strategies for further reduction of rehospitalization in modern ICD therapy.
